YAP1 and renal carcinoma: Our data suggest that the findings made in normal renal epithelial cells translate to renal cancer, permitting identification of a novel clinical signature, relying on the analysis of alterations in both YAP and WT1, which together account for a significantly poorer prognosis for patients with renal cancers.